Cargando…

Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature

BACKGROUND: WHO’s Global Programme to Eliminate Lymphatic Filariasis (LF) uses mass drug administration (MDA) of anthelmintic medications to interrupt LF transmission in endemic areas. Recently, a single dose combination of ivermectin (IVM), diethylcarbamazine (DEC), and albendazole (ALB) was shown...

Descripción completa

Detalles Bibliográficos
Autores principales:	Budge, Philip J., Herbert, Carly, Andersen, Britt J., Weil, Gary J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973625/ https://www.ncbi.nlm.nih.gov/pubmed/29768412 http://dx.doi.org/10.1371/journal.pntd.0006454

Ejemplares similares

Systems analysis-based assessment of post-treatment adverse events in lymphatic filariasis
por: Andersen, Britt J., et al.
Publicado: (2019)

Changes in Cytokine, Filarial Antigen, and DNA Levels Associated With Adverse Events Following Treatment of Lymphatic Filariasis
por: Andersen, Britt J, et al.
Publicado: (2018)

Portable infrared imaging for longitudinal limb volume monitoring in patients with lymphatic filariasis
por: Zhou, Celia, et al.
Publicado: (2019)

Efficacy and Safety of a Single Dose of Ivermectin, Diethylcarbamazine, and Albendazole for Treatment of Lymphatic Filariasis in Côte d’Ivoire: An Open-label Randomized Controlled Trial
por: Bjerum, Catherine M, et al.
Publicado: (2019)

Identification and characterization of Loa loa antigens responsible for cross-reactivity with rapid diagnostic tests for lymphatic filariasis
por: Hertz, Marla I., et al.
Publicado: (2018)

Geospatial modelling of lymphatic filariasis and malaria co-endemicity in Nigeria
por: Eneanya, Obiora A, et al.
Publicado: (2023)

Development and Introduction of the Filariasis Test Strip: A New Diagnostic Test for the Global Program to Eliminate Lymphatic Filariasis
por: Pantelias, Anastasia, et al.
Publicado: (2022)

Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d’Ivoire: A randomized controlled superiority study
por: Bjerum, Catherine M., et al.
Publicado: (2023)

A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
por: Krentel, Alison, et al.
Publicado: (2013)

A triple-drug treatment regimen to accelerate elimination of lymphatic filariasis: From conception to delivery
por: Weil, Gary J, et al.
Publicado: (2020)

Risk factors for lymphatic filariasis in two villages of the Democratic Republic of the Congo
por: Chesnais, Cédric B., et al.
Publicado: (2019)

A case study of risk factors for lymphatic filariasis in the Republic of Congo
por: Chesnais, Cédric B, et al.
Publicado: (2014)

MDA—Lymphatic Filariasis
por: Ichimori, Kazuyo
Publicado: (2014)

Urban lymphatic filariasis
por: Simonsen, Paul E., et al.
Publicado: (2012)

Accuracy of Coverage Survey Recall following an Integrated Mass Drug Administration for Lymphatic Filariasis, Schistosomiasis, and Soil-Transmitted Helminthiasis
por: Budge, Philip J., et al.
Publicado: (2016)

Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach
por: Goss, Charles W., et al.
Publicado: (2019)

Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis
por: Stolk, Wilma A., et al.
Publicado: (2013)

Elimination of Lymphatic Filariasis in The Gambia
por: Rebollo, Maria P., et al.
Publicado: (2015)

Endpoints for Lymphatic Filariasis Programs
por: Grady, Caroline A., et al.
Publicado: (2007)

A Randomized Trial of a New Triple Drug Treatment for Lymphatic Filariasis
por: King, Christopher L., et al.
Publicado: (2018)

Evaluating the Evidence for Lymphatic Filariasis Elimination
por: Davis, Emma L., et al.
Publicado: (2019)

Comparison of the Impact of Annual and Semiannual Mass Drug Administration on Lymphatic Filariasis Prevalence in Flores Island, Indonesia
por: Supali, Taniawati, et al.
Publicado: (2019)

Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis – a multicenter trial
por: Lammie, Patrick J, et al.
Publicado: (2004)

Lymphatic Filariasis Disseminating to the Upper Extremity
por: Maldjian, Catherine, et al.
Publicado: (2014)

Mapping of lymphatic filariasis in Nepal
por: Sherchand, Jeevan B, et al.
Publicado: (2003)

Impact of Community-Based Lymphedema Management on Perceived Disability among Patients with Lymphatic Filariasis in Orissa State, India
por: Budge, Philip J., et al.
Publicado: (2013)

Haiti National Program for the Elimination of Lymphatic Filariasis—A Model of Success in the Face of Adversity
por: Oscar, Roland, et al.
Publicado: (2014)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa
por: Fischer, Peter U., et al.
Publicado: (2017)

How much will it cost to eradicate lymphatic filariasis? An analysis of the financial and economic costs of intensified efforts against lymphatic filariasis
por: Kastner, Randee J., et al.
Publicado: (2017)

The design and development of a multicentric protocol to investigate the impact of adjunctive doxycycline on the management of peripheral lymphoedema caused by lymphatic filariasis and podoconiosis
por: Horton, John, et al.
Publicado: (2020)

The history of the elimination of lymphatic filariasis in China
por: De-jian, Sun, et al.
Publicado: (2013)

The burden of mental health in lymphatic filariasis
por: Ton, Thanh G.N., et al.
Publicado: (2015)

Environmental suitability for lymphatic filariasis in Nigeria
por: Eneanya, Obiora A., et al.
Publicado: (2018)

Review of Dancing Parasites in Lymphatic Filariasis
por: Dietrich, Christoph F., et al.
Publicado: (2019)

Lymphatic filariasis presenting as retroperitoneal cyst
por: Sancheti, Prachi M., et al.
Publicado: (2020)

Pacific collaboration to eliminate lymphatic filariasis
por: Ichimori, Kazuyo, et al.
Publicado: (2005)

Diagnostics to support elimination of lymphatic filariasis—Development of two target product profiles
por: Won, Kimberly Y., et al.
Publicado: (2021)

A Case of Filariasis: Removal of Lymphatic Varix by Operation
por: Bush, J. Paul, et al.
Publicado: (1907)

Comparing antigenaemia- and microfilaraemia as criteria for stopping decisions in lymphatic filariasis elimination programmes in Africa
por: Stolk, Wilma A., et al.
Publicado: (2022)

Lymphatic filariasis in Zambia: A scoping review protocol
por: Shirley, Hugh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jvdmjbl0ocs036oskegcfmjngg